U.S., Dec. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07288931) titled 'Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma' on Dec. 04.
Brief Summary: The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).
Study Start Date: Aug. 06, 2024
Study Type: INTERVENTIONAL
Condition:
Pheochromocytoma/Paraganglioma (PPGL)
Intervention:
DRUG: Diagnostic Test: Al18F-NOTA-LM3
Patients will receive a single intravenous injection of Al18F-NOTA-LM3. Subsequently, a PET/CT scan will be performed within 60 to 120 minutes post-injection.
DRUG: Diagnostic Test: 68...